Relatively “simple” tumors, such as some cases of chronic myeloid leukemia or HER2-positive breast cancer, whose growth is driven by a key molecular alteration, can experience long-lasting remissions and likely cure with targeted treatments [202,203,204,205]. This evidence concerns the gene ERBB2 and breast cancer.